These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35668930)

  • 21. A pan-cancer analysis of RNASEH1, a potential regulator of the tumor microenvironment.
    Yi C; Yang J; Zhang T; Xie S; Li W; Qin L; Chen D
    Clin Transl Oncol; 2023 Aug; 25(8):2569-2586. PubMed ID: 37022517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-omics analysis of TLCD1 as a promising biomarker in pan-cancer.
    Wang S; Zhang M; Sun H; Li T; Hao J; Fang M; Dong J; Xu H
    Front Cell Dev Biol; 2023; 11():1305906. PubMed ID: 38559424
    [No Abstract]   [Full Text] [Related]  

  • 23. A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis.
    Chen R; Wu W; Chen SY; Liu ZZ; Wen ZP; Yu J; Zhang LB; Liu Z; Zhang J; Luo P; Zeng WJ; Cheng Q
    Front Immunol; 2022; 13():831542. PubMed ID: 35979347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer.
    Yu Y; Sun Y; Li Z; Li J; Tian D
    BMC Bioinformatics; 2023 Feb; 24(1):44. PubMed ID: 36765282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
    Song J; Yang R; Wei R; Du Y; He P; Liu X
    Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
    Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
    Front Oncol; 2022; 12():927988. PubMed ID: 35756681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker.
    Meng W; Jiang Z; Zhang X; Cai B; Ma L; Guan Y
    Comput Math Methods Med; 2022; 2022():3119721. PubMed ID: 36466552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic Investigation of the Multifaceted Role of
    Sun Q; Du J; Dong J; Pan S; Jin H; Han X; Zhang J
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
    Jin D; Yuan L; Li F; Wang S; Mao Y
    BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systemic pan-cancer analysis of MPZL3 as a potential prognostic biomarker and its correlation with immune infiltration and drug sensitivity in breast cancer.
    Huang R; Li L; Wang Z; Shen K
    Front Oncol; 2022; 12():901728. PubMed ID: 35965540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
    Ju Q; Li XM; Zhang H; Zhao YJ
    Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune Infiltration of MMP14 in Pan Cancer and Its Prognostic Effect on Tumors.
    Li M; Li S; Zhou L; Yang L; Wu X; Tang B; Xie S; Fang L; Zheng S; Hong T
    Front Oncol; 2021; 11():717606. PubMed ID: 34604053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERH Impacts Patient Prognosis and Tumor Immune Microenvironment: A Pan-Cancer Analysis.
    Gong Q; Li Q; Shen X; Xu Z
    Comb Chem High Throughput Screen; 2024 Apr; ():. PubMed ID: 38584561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic analysis of the prognostic value and immunological function of LTBR in human cancer.
    Wu Y; Zhao S; Guo W; Liu Y; Requena Mullor MDM; Rodrìguez RA; Wei R
    Aging (Albany NY); 2024 Jan; 16(1):129-152. PubMed ID: 38175686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRAME Is a Potential Carcinogenic Biomarker that Correlates with Patient Prognosis and Tumor Immunity Based on Pan-Cancer Analysis.
    Zhao Q; Zhang Z; Wu Y
    Ann Clin Lab Sci; 2022 Mar; 52(2):185-195. PubMed ID: 35414497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggresome-Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma.
    Zhang Z; Zhang X; Huang A
    Front Oncol; 2021; 11():718589. PubMed ID: 34485153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pan-Cancer Integrated Analysis of HSF2 Expression, Prognostic Value and Potential Implications for Cancer Immunity.
    Chen F; Fan Y; Liu X; Zhang J; Shang Y; Zhang B; Liu B; Hou J; Cao P; Tan K
    Front Mol Biosci; 2021; 8():789703. PubMed ID: 35087869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An integrative prognostic and immune analysis of PTPRD in cancer.
    Ou C; Peng Q; Zeng C
    Math Biosci Eng; 2022 Mar; 19(6):5361-5379. PubMed ID: 35603359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer.
    Zhang L; Li X; Zhang J; Xu G
    Front Cell Dev Biol; 2021; 9():763674. PubMed ID: 35127701
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.